SYNAGEVA BIOPHARMA CORP Insider Trading for June 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SYNAGEVA BIOPHARMA CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in SYNAGEVA BIOPHARMA CORP for June 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 57.56 | 400 | 23,024 | 39,600 | |
| Jun 26 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | M | 40.32 | 300 | 12,096 | 39,700 | |
| Jun 26 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Sell | S | 108.02 | 700 | 75,614 | 266 | 966 to 266 (-72.46 %) |
| Jun 26 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 57.56 | 400 | 23,024 | 966 | 566 to 966 (+70.67 %) |
| Jun 26 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Buy | M | 40.32 | 300 | 12,096 | 566 | 266 to 566 (+112.78 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Option Exercise | M | 25.00 | 1,375 | 34,375 | 0 | ||
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Sell | S | 100.00 | 1,375 | 137,500 | 0 | 1.4 K to 0 (-100.00 %) | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Buy | M | 25.00 | 1,375 | 34,375 | 1,375 | 0 to 1.4 K | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | M | 60.45 | 4,250 | 256,913 | 0 | |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 223,864 | 219.6 K to 223.9 K (+1.94 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 8,184,771 | 8.2 M to 8.2 M (+0.05 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 112,740 | 108.5 K to 112.7 K (+3.92 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 1,748,315 | 1.7 M to 1.7 M (+0.24 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 67,729 | 63.5 K to 67.7 K (+6.70 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 177,463 | 173.2 K to 177.5 K (+2.45 %) |
| Jun 24 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Buy | M | 60.45 | 4,250 | 256,913 | 219,050 | 214.8 K to 219.1 K (+1.98 %) |
| Jun 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Option Exercise | M | 23.95 | 1,000 | 23,950 | 1,000 | ||
| Jun 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Sell | S | 90.00 | 1,000 | 90,000 | 0 | 1,000 to 0 (-100.00 %) | |
| Jun 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Buy | M | 23.95 | 1,000 | 23,950 | 1,000 | 0 to 1,000 | |
| Jun 16 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Option Exercise | M | 23.00 | 1,000 | 23,000 | 8,375 | ||
| Jun 16 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Sell | S | 83.31 | 1,000 | 83,310 | 0 | 1,000 to 0 (-100.00 %) | |
| Jun 16 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Buy | M | 23.00 | 1,000 | 23,000 | 1,000 | 0 to 1,000 | |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Option Exercise | M | 8.73 | 18,637 | 162,701 | 49,066 | |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Option Exercise | M | 0.95 | 1,034 | 982 | 0 | |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Option Exercise | M | 0.95 | 1,926 | 1,830 | 0 | |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Sell | S | 80.00 | 21,597 | 1,727,760 | 459 | 22.1 K to 459 (-97.92 %) |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Buy | M | 0.95 | 1,034 | 982 | 22,056 | 21 K to 22.1 K (+4.92 %) |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Buy | M | 8.73 | 18,637 | 162,701 | 21,022 | 2.4 K to 21 K (+781.43 %) |
| Jun 12 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Buy | M | 0.95 | 1,926 | 1,830 | 2,385 | 459 to 2.4 K (+419.61 %) |
| Jun 06 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER FELIX | Director | Option Exercise | A | 80.35 | 15,000 | 1,205,250 | 15,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | A | 80.35 | 45,000 | 3,615,750 | 45,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quart Barry D | Option Exercise | A | 80.35 | 7,500 | 602,625 | 7,500 | ||
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | WIRTH PETER | Option Exercise | A | 80.35 | 7,500 | 602,625 | 7,500 | ||
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Williams Glen | SVP, Technical Oper ... | Option Exercise | A | 80.35 | 45,000 | 3,615,750 | 45,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | A | 80.35 | 120,000 | 9,642,000 | 120,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | TISCH THOMAS J | Option Exercise | A | 80.35 | 7,500 | 602,625 | 7,500 | ||
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Malley Thomas | Option Exercise | A | 80.35 | 7,500 | 602,625 | 7,500 | ||
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Heberlig Chris | Group Vice Presiden ... | Option Exercise | A | 80.35 | 12,000 | 964,200 | 12,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Goldberg Mark Alan | EVP, Medical & Reg. ... | Option Exercise | A | 80.35 | 30,000 | 2,410,500 | 30,000 | |
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | DAVIS STEPHEN | Option Exercise | A | 80.35 | 7,500 | 602,625 | 7,500 | ||
| Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | A | 80.35 | 40,000 | 3,214,000 | 40,000 |